[ad_1]
(AWP / Reuters / SPU) The Swiss stock market is on track to consolidate after the past two weeks and is barely in equilibrium. In a meeting until then uninspired with hardly new information, the Swiss Market Index (SMI ( SMI 8831.32 -0.34% ) ) runs around the zero line. The ongoing trade dispute between the United States and China continues to prevent brokers from panicking. On the occasion of the EU-China Beijing Summit, Chinese Premier Li Keqiang said China did not want a trade war with the United States, leaving the problem in the background for now.
Trading laterally. Around noon, it slips relatively less, but can stay above the mark of 8800 points.
The global market is slowed notably by the weak development of heavy goods vehicles. Novartis ( NOVN 78.74 -0.53% ) and Rock ( ROG 231.05 – 0.71% ) as well as Nestle ( NESN 79.52 -0.45% ) yield easily. Following the strong performance of the past two weeks, Novartis is making a slight profit-taking. The approval in Switzerland for the migraine medication Aimovig is considered barely price sensitive in market circles. However, Novartis is also focusing because the publication of half-yearly figures is expected Wednesday
Extra burden on financial stocks as Julius Baer ( BAER 57.56 – 0.31% ) [SwissLife ( SLHN 344.8 -0.26% ) or Zurich Insurance ( ZURN 296.4 -0.74% ) the global market something. On the other hand, Credit Suisse ( CSGN 15.045 1.18% ) marks the summit of the SMI. Also UBS ( UBSG 15.1 0.23% ) are increasing
Rieter is moving into the large market ( NOTHING 177.2 4.54% ) after the asset manager Veraison reported a share of a good 3%. Veraison announced Saturday that it had purchased 141,624 registered shares of Rieter, representing a total of 3.03%
Ems-Chemie ( EMSN 640 1.59% ) continue Friday's upward trend to good half-year results. There was a strong rebound after strong numbers and prospects, he said in the market. Above all, it was convincing that Ems-Chemie was able to raise prices. The documents are now ripe for an approximation of the annual summit.
Technological values such as AMS ( AMS 70.78 1.17% ) Logitech ] [ LOGN 45.67 19659020] 0.42% ) and Temenos ( TEMN 158 0.25% ) tend to increase
Cassiopeia ( SKIN 58.6 3.9% ) . The pharmaceutical company has published results of Phase 2 positive studies for the drug Clascoterone for the treatment of hair loss. In addition, Credit Suisse raised its target price from CHF 42 to CHF 66.
In contrast, the shares of another biotech company clearly lose interest. Obseva ( OBSV 17.5 -12.5% ) who celebrated their SIX debut Friday with an explosion of 33% of the stock price, losing ground.
Leonteq derivatives specialist papers ( LEON 60.05 3.45% ) with clear advances fall.
Lower Asia – Tokyo Closed
Asian markets tend to be weaker. China's latest economic data fuel investors' skepticism that the country is not easily coping with the consequences of a trade war with the United States. In Japan, stock exchanges are closed today on Monday due to a public holiday. A little lower is Hang Seng in Hong Kong (-0.1%). The South Korean Kospi ( Kospi 2300.97 -0.47% ) loses 0.3%. The Shanghai Composite (-0.6%) and Australian S & P / ASX 200 (-0.5%) are slightly lower.
Dollar-franc: lower than parity price
Euros go up to the dollar. The common currency is trading at US $ 1,1706 in US currency. The franc goes up. The euro is currently trading below the 1.17 to CHF 1.1692 mark against the Swiss currency, the dollar is unable to maintain the nominal value of the Swiss franc and is currently trading at CHF 0.9993
Decline in the price of oil
by. A barrel of (159 liters) North Sea Brent ( Brent 73,866 -2,56% ) cost $ 75. The price of gold is trading at $ 1243 troy ounce.
Source link
